Key Dates

Related Announcements

• December 9, 2024 - BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed).  See NOFO RFA-EY-25-001. 

Issued by

National Eye Institute (NEI)

Purpose

The purpose of this notice is to change the Funding Opportunity Goals for RFA-EY-25-001 BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed).  Changes to the NOFO are shown in bold and Italics below;

Currently Reads:

Part 1. Overview Information

Funding Opportunity Goal(s) 

1) To support eye and vision research projects that address the leading causes of blindness and impaired vision in the U.S. These include retinal diseases; corneal diseases; cataract; glaucoma and optic neuropathies; strabismus; amblyopia; and low vision and blindness rehabilitation. 2) To increase understanding of the normal development and function of the visual system in order to better prevent, diagnose, and treat sight-threatening conditions; and, to enhance the rehabilitation, training, and quality of life of individuals who are partially-sighted or blind. 3) To support a broad program of basic vision research through grants and cooperative agreements; to encourage high quality clinical research, including clinical trials, other epidemiological studies, and health services research; to encourage research training and career development in the sciences related to vision; and to sponsor scientific workshops in high priority research areas to encourage exchange of information among scientists.

Modified to read:

Part 1. Overview Information

Funding Opportunity Goal(s) 

To provide extramural research support for the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative’s aim of revolutionizing our understanding of the brain and its function in unprecedented detail. The NIH BRAIN Initiative’s focus is foundational development of new technologies and tools to map, monitor, and modulate brain circuits in model systems and humans – toward the ultimate goal of treating and curing human brain disorders.

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Martha Flanders, PhD
National Eye Institute (NEI)
Telephone: 301-827-5191
Email: [email protected]